Dec
2026
Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
Visit us
stand H1.W66
Zone

Linnea SA

Exhibitor at CPHI Middle East 2026
About Us

Founded in 1982, Linnea is a leading Swiss manufacturer of premium botanical active pharmaceutical ingredients for the pharmaceutical, cosmetics and natural food industries. With over 40 years of expertise, we remain committed to innovation, quality and sustainability. Operating from our GMP-certified facility and following GACP guidelines, we ensure exceptional product standards. Our validated processes rely on the finest raw materials from trusted global suppliers, stringent controls and standardized production allow us to deliver reliable batch-to-batch consistency at all times.

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Switzerland
  • Founded:
    1982
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    50 - 99
Company types
Manufacturer/Innovator
Primary activities
API Producer
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Middle East 2026
  • 14 Dec 2026 - 16 Dec 2026
  • Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
  • Visit us at stand H1.W66

Products Featured at CPHI Middle East 2026

  • HMRlignan

    Product HMRlignan

    Lignans are plant compounds with well-established bioactive properties, known to support vitality and resilience in plants. Linnea's HMRlignan is a rich source of lignans, providing a significantly higher concentration compared to typical dietary sources. Highly purified Norway Spruce lignans. 7-HMR co-cry...
  • Red Clover

    Product Red Clover

    Linnea’s Red Clover botanical extract is extracted using a unique formula, balancing the main four Red Clover isoflavones,consistent through every batch. Linnea thus ensures consistent quality and standardization of Red Clover. 
  • Vincamine

    Product Vincamine

    Vincamine is a semi-synthetic derivative, extracted using a proprietary methodto Linnea, vetted to GMP-standard quality controls, obtaining a state-of-theartproduct. Vincamine is CEP certified, and complies with Ph.Eur. monograph“Vincamine”, that Linnea developed.
  • Vinpocetine

    Product Vinpocetine

    Linnea’s Vinpocetine is a semi-synthetic derivative, extracted using a provenmethod, vetted with in-house GMP-standard quality controls, resulting in ahigh-quality profile and outstanding therapeutic value end product. Linnea’sVinpocetine is compliant with the European Pharmacopoeia and is CEP certified.
  • Butylscopolamine

    Product Butylscopolamine

    Linnea’s Vinpocetine is a semi-synthetic derivative, extracted using a provenmethod, vetted with in-house GMP-standard quality controls, resulting in ahigh-quality profile and outstanding therapeutic value end product. Linnea’sVinpocetine is compliant with the European Pharmacopoeia and is CEP certified.

Linnea SA Resources (1)

  • Biogas: Linnea as a suistainable company

    Video Biogas: Linnea as a suistainable company

    Sustainability is a company-wide priority:we partner with local farmers in the Swiss canton of Ticino converting organic waste into energy thanks to a biogas plant, and we voluntarily adhere to the Swiss Private Sector Energy Agency Program, for a minimal CO2 footprint.
    2024-09-16